Your browser doesn't support javascript.
A retrospective study of risk factors of Mucormycosis in COVID-19 patients at a dedicated COVID hospital
National Journal of Physiology, Pharmacy and Pharmacology ; 12(9):1393-1398, 2022.
Article in English | ProQuest Central | ID: covidwho-2025154
ABSTRACT
Over use of steroids, uncontrolled blood sugar levels, oxygen therapy, long hospital stay, and ICU procedures and ventilators also contribute to the increased occurrence of post-COVID Mucormycosis. Hot and humid climate favors the growth of such molds. [...]many studies have found that hospitals in our country have very heavy mold spore count. [...]steroid-induced hyperglycemia may also be an important risk factor for COVID-associated Mucormycosis. [...]the present retrospective cross-sectional study was planned to study and analyze the risk factors of COVID 19 associated Mucormycosis infection.
Keywords

Full text: Available Collection: Databases of international organizations Database: ProQuest Central Type of study: Observational study / Prognostic study Language: English Journal: National Journal of Physiology, Pharmacy and Pharmacology Year: 2022 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: Databases of international organizations Database: ProQuest Central Type of study: Observational study / Prognostic study Language: English Journal: National Journal of Physiology, Pharmacy and Pharmacology Year: 2022 Document Type: Article